(NASDAQ:CRBP), NORWOOD, Mass., Jan. 28, 2025 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will be participating in the Guggenheim SMID Cap Biotech Conference, to be held February 5-6, 2025 in New York, NY Dr. Cohen will participate in […]
(NASDAQ:IPGP), MARLBOROUGH, Mass., Jan. 28, 2025 (GLOBE NEWSWIRE) — IPG Photonics Corporation (Nasdaq: IPGP) will release its fourth quarter 2024 financial results before the market opens on Tuesday, February 11, 2025. The Company will hold a conference call to review these results at 10:00 a.m. ET on the same day. To access the call, please
(TSX:STN),(NYSE:STN), EDMONTON, Alberta, Jan. 28, 2025 (GLOBE NEWSWIRE) — TSX,NYSE: STN Stantec, a global leader in sustainable design and engineering, will release its fourth quarter and full-year 2024 financial results before markets open on Tuesday, February 25, 2025. A webcast and conference call to discuss the Company's performance will be held the same day at
SCHAFFHAUSEN, Switzerland, Jan. 28, 2025 (GLOBE NEWSWIRE) — Acronis, a global leader in cybersecurity and data protection, has unveiled the findings of its inaugural report, Data Privacy in 2025: A survey to explore consumer views on cyber protection. Released in alignment with Data Privacy Day on January 28, the report provides insights into global consumer
(NYSE MKT:CLDI), SAN DIEGO, Jan. 28, 2025 (GLOBE NEWSWIRE) — Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced that its ending cash balance at December 31, 2024 was approximately $9.6 million. Due to Calidi's bolstered cash balance and success in recent fundraising,
(NYSE:SYY), HOUSTON, Jan. 28, 2025 (GLOBE NEWSWIRE) — Sysco Corporation (NYSE: SYY) (“Sysco” or the “company”) today announced financial results for its 13-week second fiscal quarter ended December 28, 2024. Key financial results for the second quarter of fiscal year 2025 include the following (comparisons are to the same period in fiscal year 2024): Sales
(NasdaqGM:LFMD),(NasdaqGM:LFMDP), NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) — LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced its participation in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference being held February 11-12, 2025, at the Cliff Lodge in Snowbird, Utah. Management will hold one-on-one
(NASDAQ:MGX),(NasdaqGM:CLLS),(NASDAQ:CBUS), EMERYVILLE, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) — Totus Medicines, a company revolutionizing small molecule drug discovery and development using covalent DNA-encoded libraries and AI tools, today announced the appointment of Simon Harnest, MSc, BSc, as Chief Financial Officer. This key addition comes at a pivotal moment for Totus as the company prepares to
SAN FRANCISCO, Jan. 28, 2025 (GLOBE NEWSWIRE) — Today, GoodTime released its fourth annual Hiring Insights Report, a comprehensive analysis based on an independent study of over 500 U.S. talent acquisition (TA) leaders, revealing the most pressing challenges and emerging trends shaping the hiring landscape in 2025. The report uncovers a challenging talent market where
SOUTH SIOUX CITY, Neb., Jan. 28, 2025 (GLOBE NEWSWIRE) — Lighthouse Autism Center, South Sioux City, Nebraska, a leading provider of center-based Applied Behavior Analysis (ABA) therapy, is thrilled to announce the opening of its newest center in South Sioux City, Nebraska, on February 24, 2025. This marks a significant expansion for Lighthouse Autism Center,